At the initial stage of the disease, insulin resistance is compensated by increased pancreatic β-cells mass and insulin secretion, however, as the disease progresses, pancreatic β-cells mass and function gradually decline leading to decreased uptake of glucose into skeletal muscle, liver and adipose tissue resulting in uncontrollable hyperglycemia [3]. The gene discussed is INS; the disease is Hyperglycemia.